Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round. The investment was led by Marubeni, with whom the company has been developing the Japanese market since 2017. The round saw further investment from Capitol Health, who previously led the company's Series A in 2016, as well as new participation from several top investors in Australia. Approximately 10 percent of the round was set aside for individual radiologists and other physicians who have either trained or used the company’s medical AI solutions. Enlitic plans to use the funding to enhance its artificial intelligence product portfolio, expand its engineering and data scientist teams, and focus on regulatory approval for clinical use in the U.S., Australia, Japan, Europe, Canada and Brazil.

Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared to myomectomy, according to new research presented at the Society of Interventional Radiology’s (SIR) 2019 Annual Scientific Meeting, March 23-28 in Austin, Texas. Women who received this minimally invasive treatment also had a slightly lower need for additional treatment than those who underwent surgery.

Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla.

IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology Center at MedStar Southern Maryland Hospital Center, based on an IBA Dosimetry independent beam scanning solution.

Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are expected to drive growth of virtual reality (VR) in the healthcare market over the next several years, according to new research from Reports and Data. The report projects the market will reach a value of $6.91 billion by 2026. Advancements in the field of information technology (IT), including laptop, computer, internet connectivity and mobile applications will also be a significant factor stimulating market demand.

SuperSonic Imagine will introduce the new generation of its Aixplorer Mach 30 breast ultrasound solution at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla. The SBI‘s annual symposium is the largest breast imaging conference in the world and this year, the symposium will focus on Value in Breast Imaging. SuperSonic Imagine will highlight new features and better performance with features like SWE Plus and SonicPure.